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Objectives. This study sought to compare the estimated glomerular filtration rate and the indication 
of dose adjustment of antimicrobials when using Cockcroft-Gault or Modification of Diet in Renal 
Disease. Methods. A cross-sectional study was performed with patients admitted to the intensive care 
unit of a Brazilian general hospital. The glomerular filtration rate was calculated for patients on all 
days using the Cockcroft-Gault and Modification of Diet in Renal Disease equations. The difference 
in estimated glomerular filtration and the dose adjustment indication of antimicrobials were assessed. 
Results. A total of 631 patients were included in this study. The median estimated glomerular filtration 
was significantly higher when estimated using Modification of Diet in Renal Disease (100.3 mL/
min/1.73 m²) than the estimation by Cockcroft-Gault (83.2 mL/min) [p<0.001]. Greater differences 
in estimations produced by the two formulae were observed in patients at extremes of weight and 
age, and a different dose adjustment was indicated for all antimicrobials assessed. Conclusions. 
These results demonstrate a significant difference in estimated glomerular filtration rate values when 
calculated using either Cockcroft-Gault or Modification of Diet in Renal Disease as well as in the 
indication of dose adjustment in an intensive care unit. 
Keywords: Intensive Care Units. Glomerular Filtration Rate. Anti-infective Agents. Renal 
Insufficiency.
INTRODUCTION
Kidney disease affects approximately 850,000 
people annually around the world and represents the 
12th leading cause of mortality in the general population 
(WHO, 2018). Patients affected by loss of renal function 
present with a high risk of adverse drug events, 
particularly due to the changes in the pharmacokinetics 
of numerous renally excreted substances. This results in 
a need to adjust dosages with the aim of administering 
an optimal dose and reducing the risk of toxicity. 
In addition, drug overdose prescriptions have often 
been associated with the loss of renal function since 
many medications, including antihypertensive drugs, 
antimicrobials and analgesics, are contraindicated or 
require special care in cases such as these (Karsch-
Volk et al., 2013; Nielsen et al., 2014). These drugs are 
widely used in the intensive care unit, where loss of 
renal function occurs in higher incidence (Cardinal et 
al., 2012; Uchino et al., 2005).
Acute kidney injury (AKI) is a very common 
condition in ICU patients and is associated with 
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mortality rates of 50-60%, despite the advances of 
medical care (Tejera et al., 2017). Therefore, accurately 
assessing the kidney function in critically ill patients 
is pivotal to reduce the severity of complications by 
supportive therapy as stabilization of the hemodynamic 
status, prompt treatment of any underlying disease 
and carefully assessment of nephrotoxic drugs use 
(Bragadottir, Redfors, Ricksten, 2013; Macedo, Mehta, 
2013). In addition, it is essential for the appropriate 
dosing of drugs aiming to avoid toxicity caused by 
overdose (Pazhayattil, Shirali, 2014).
The glomerular filtration rate (GFR) is considered 
the best marker for monitoring renal function throughout 
its diagnosis, staging, and progression (Katsube et 
al., 2017). It can be precisely measured by markers 
such as iohexol, inulin, iodine-125 iothalamate, Cr-51 
ethylenediaminetetraacetic acid (Cr-51 EDTA), and 
Tc-99m diethylenetriaminepenta-acetic acid (Tc-99m 
DTPA). However, these tests are expensive, laboriousness, 
and generally unavailable in routine hospital settings 
(Martin et al., 2011). Given these drawbacks to 
calculating GFR, equations such as the Modification of 
Diet in Renal Disease (MDRD) and Cockcroft-Gault 
(CG), which estimate GFR and creatinine clearance 
level, respectively, have been developed and used for 
this purpose (Cockcroft, Gault, 1976; Levey et al., 
2006). However, although widely employed, these two 
equations are limited in their use (Helou, 2010).
The CG equation is based in data from a study 
conducted in 1973 that included 236 patients aging 
from18 to 92 years, with mean weight of 72 kg. From 
that total, only 10 patients were females. The CG 
equation includes age, sex, total body weight and serum 
creatinine (Cockcroft, Gault, 1976). On the other hand, 
MDRD is based on a study including patients with 
chronic renal disease, which assessed the clearance of 
iotalamato-I125. The brief form of MDRD includes the 
variables age, sex, ethnicity and serum creatinine and 
in the complete form, two other variables are included: 
serum albumin and blood urea nitrogen (BUN) (Levey 
et al., 1999; Levey et al., 2006).
Using the creatinine as a marker of renal function 
have some limitation since it is influenced by several 
factors as muscle mass, protein intake, physical activity 
or the use of medicines. In addition, the creatinine is 
excreted at a variable rate that increases as the renal 
failure progresses. Therefore, the clearance of creatinine 
overestimates the real value of the glomerular filtration 
rate (Kumar, Mohan, 2017). 
Given the potential complications and risks 
associated with the avoidance of drugs during reduced 
GFR, several studies have addressed this subject. 
However, despite the higher incidence of renal 
dysfunction and the lack of standards in dose adjustments 
during ICU admission, there are few studies that have 
assessed the appropriateness of the equations and drug 
doses in patients with RF under intensive care.
This study sought to compare the estimated GFR 
(eGFR) and the recommendations for dose adjustment 
of broad-spectrum antimicrobials using CG and 
4-Variable MDRD as well as the differences according 
to age and weight.
METHODS
This was a cross-sectional study, performed in a 
general hospital located in state of Bahia, in Brazilian 
Northeast. This institution is classified as a medium- 
and high-complexity urgent and emergency hospital 
that serves 134 municipalities with a total of 254 beds 
(Bahia, 2015). Data were collected from medical records 
using a form developed in the KoBoToolbox for Android 
(available at: www.kobotoolbox.org).
All patients admitted between January 2014 and 
December 2015 who were older than 18 years of age 
were included in this study. Patients who stayed in the 
ICU for less than 24 hours, who underwent dialysis or 
another renal replacement therapy, or whose missing 
data did not allow for the calculation of eGFR were 
excluded from this study.
All information contained in the medical records 
of patients was monitored and analysed from the day 
before ICU admission to the last day of hospitalization 
in ICU. The following data were collected from patients 
records: cause of admission, previous location of the 
patient before UCI admission (source), weight, height 
and serum creatinine. Then, these data were transferred 
to a database for further analysis.
The eGFR was calculated for each day of 
hospitalization in the ICU, using online calculators from 
the Brazilian Nephrology Society website (available at: 
https://sbn.org.br/utilidades/calculadoras/) and double 
checked using the following formulae:
CG: [(140 - age) x weight/(72 x serum creatinine)] x 
0.85 (if female)(Cockcroft, Gault, 1976).
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MDRD: (186 x serum creatinine)- 1.154 x age- 0.203) 
x 0.742 (if female) x 1.21 (if African American) (Levey 
et al., 2006).
Additionally to the comparison between the 
GFR estimated by CG and MDRD-4, we assessed 
the difference for dose adjustment recommendations 
when using the CG or MDRD-4 equations. Therefore, 
we choose the top five intravenous broad-spectrum 
antimicrobials requiring dose adjustments in patients 
with reduced glomerular filtration rate, used in our 
institution: vancomycin, meropenem, piperacillin/
tazobactam, cefepime, and fluconazole. The need for 
dose adjustment was assessed based on the following 
sources of information: Micromedex Healthcare 
Series® and AHFS – Drug Information Handbook 2015 
(Micromedex, 2016; APhA, 2015). 
Data were analysed with SPSS 23.0. Continuous 
variables are presented as the median and corresponding 
measure of dispersion. Proportions were compared 
using Pearson’s chi-squared test. We compared median 
values between groups using the Wilcoxon signed-rank 
test, with a significance of 5%. 
Ethical: The study was approved by the Research 
Ethics Committee at Multidisciplinary Institute 
of Health, Federal University of Bahia, Vitória da 
Conquista, Brazil, with number: 1.460.914 
RESULTS
The study included 631 patients. Table I describes 
the clinical and demographic characteristics of the 
population.
Most patients were male (64.2%) with a median 
weight of 69.3 kg. Admissions were most frequently due 
to neurological (34.6%) and surgical (32.3%) causes.
Median eGFR was 100.3 mL/min/1.73 m² for 
MDRD-4 and 83.2 mL/min for CG (p < 0.001). 
Due to differences in eGFR results calculated 
using the CG or MDRD, there may be differences in the 
indication of drug dose adjustment. In table II, for each 
chosen antimicrobial, is compared the number of times 
the dose adjustment should be conducted according to 
the respective eGFR range, following the recommended 
dose adjustment, when the GFR is estimated by CG and 
MDRD-4 equations. 
The study showed a greater difference in eGFR 
between equations in patients at extremes of weight 
and age. Figures 1 and 2 show the relationship between 
median eGFR, as determined using CG and MDRD-4 
versus weight and age, respectively.
Table I - Demographic characteristics of the study population
Characteristics (N=631)





Surgery centre 154 (24.4)
Surgical clinic 43 (6.8)
Other hospital 56 (8.9)
Medical clinic 28 (4.4)
Other 1 (0.2)








Drug ingestion and overdose 9 (1.4)
Others 109 (17.3)
Median (IQR*) 
Age (years) 50 (32 - 67)
Weight (kg) 70 (60 - 75)
Baseline serum creatinine 1 (0.7 - 1.9)
Length of stay in Intensive Care Unit 6 (3 - 12)
*Interquartile range
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Table II - Frequency of dose adjustment according to recommended for each estimated glomerular filtration range calculated 










10 - 50 1587 (28.7) 1377 (24.9)
p < 0.001
< 10 65 (1.2) 78 (1.41)
Meropenem 
25- 50 891 (16.1) 797 (14.4)
p < 0.00110 - 25 696 (12.6) 580 (10.5)
< 10 65 (1.2) 78 (1.4)
Cefepime 
30 - 60 1062 (19.2) 854 (15.4)
p < 0.00111 - 30 832 (15) 729 (13.2)
< 11 88 (1.6) 103 (1.9)
Piperacillin/Tazobactam
20 - 40 849 (15.4) 741 (13.4)
p < 0.001
< 20 473 (8.6) 408 (7.4)
Fluconazole < 50 1652 (19.9) 1455 (26.3) p < 0.001
Figure 1 - Median estimated glomerular filtration rate calculated using MDRD-4 or Cockcroft-Gault versus age group.
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Figure 2 - Median estimated glomerular filtration rate calculated using MDRD-4 or Cockcroft-Gault versus weight range.
DISCUSSION
This study demonstrated a significant difference in 
eGFR in ICU patients when calculated using MDRD-
4 and CG. Disagreements between the equations 
raise doubts about how the dose adjustment should be 
performed, which can lead to serious errors, including 
medication errors. To reduce this difference between 
the equations, eGFR can be calculated using the body 
surface area (BSA), although this data is difficult to 
obtain in medical records. Furthermore, in many 
cases, its measurement is imprecise. In addition, the 
impact of BSA correction seems to be limited (Roblin 
et al., 2009). 
As observed in Figure 1, in the age group of 50 
to 59 years, eGFR values  are similar, although the 
difference becomes more significant with advanced age. 
This difference between eGFR, as calculated by either 
CG or MDRD-4, in elderly patients has been previously 
observed. It was found that GFR, when compared to 
the gold standard, was underestimated when calculated 
using CG and overestimated when calculated using 
MDRD (Saha et al., 2015). Similarly, a study showed 
a difference in dose adjustment between the equations 
for drugs, such as amantadine and digoxin, which are 
commonly used in elderly patients (Gill et al., 2007). 
In this population, it is common to find patients with 
reduced muscle mass and, consequently, very low serum 
creatinine levels. Some studies suggest rounding these 
creatinine levels  to 1 mg/dL, although this practice 
may lead to an underestimation of creatinine clearance 
levels. Thus, some studies continue to suggest using CG 
as a safer option for these patients since use of MDRD-4 
results in a higher estimation of GFR, which may result 
in higher adjusted doses.
In this study, the difference observed between 
eGFR calculated using either CG or MDRD-4 was also 
significantly increased at extremes of weight, as seen 
in Figure 1. As expected, up to the weight range of 70-
79 kg, eGFR as calculated using CG is lower than that 
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calculated using MDRD-4. This is because only the CG 
equation considers weight, which is a positive factor 
in this equation. Conversely, GFR tends to be higher 
in obese patients than in the rest of the population, 
which causes a greater discrepancy in GFR and more 
dramatically affects the adjustment of drug dosage 
(Jesudason, Clifton, 2012; Nyman et al., 2011).
In our study, we used the total body weight 
(TBW) of the patients, since this is the recommended 
weight used in the original study that defined the CG 
equation (Cockcroft, Gault, 1976). Some authors state 
that the use of ideal body weight (IBW) is indicated for 
patients at the extremes of weight, although, in these 
cases, an underestimation of GFR may occur (Hudson, 
Mason, Huch, 2011). Other authors indicate the use of 
a cofactor to increase the reliability of the CG equation 
(Wilhelm, Kale-Pradhan, 2011). Therefore, prior to drug 
dose adjustment, it is important to seek guidance from 
the pharmaceutical company that produces the drug 
to determine whether the recommendation for dose 
adjustment is made based on TBW or IBW. In some 
cases, this information can be found in the package 
leaflet (Nyman et al., 2011). 
In patients at extremes of weight and age, who 
showed higher eGFR difference between the equations, 
the results suggest a need for greater care in the 
application of the equations. Many studies have been 
conducted with specific groups and have compared them 
with the gold standard, although there is no clear answer 
as to the best form and equation to calculate eGFR. 
A feature similar to both equations used to 
calculate eGFR is the dependence on serum creatinine. 
Both serum creatinine and BUN are often excreted by 
kidneys in a constant way and therefore are commonly 
used as markers to assess renal function. Although, 
since several factors such as muscle mass, diet, 
hydration, analytical variations or even ethnicity can 
influence the excretion of these two markers, their use 
in some groups may be not safe for eGFR (Kumar, 
Mohan, 2017). The Brazilian population is the result 
of an intense process of miscegenation between 
several different ethnicities, including Europeans, 
black Africans, and indigenous people, which resulted 
from colonization and the intense immigration that 
occurred in recent centuries (Brasil, 2009). Thus, 
unlike previous data from groups with low ethnic 
variability, the results of this study were obtained from 
a widely multiracial population. Likewise, this study 
included ICU patients who are frequently affected 
by hemodynamic instability, which other studies 
have found to be an uncommon condition (Potes 
et al., 2017).
In order to assess the patient throughout the 
hospitalization period and to consider all variability that 
occurs during that period, such as weight changes, diet, 
and use of medications, the GFR was estimated daily 
using both equations and all test results were classified 
according to the creatinine clearance range used to 
indicate the dose adjustment (Table II). In agreement 
with previous data (Golik, Lawrence, 2008; Kumar, 
Mohan, 2017), this study demonstrated that different 
suggestions of dose adjustment could occur according to 
the equation used for eGFR. For all creatinine clearance 
ranges, significant differences were found between 
test results. These results indicate that deciding which 
dose should be prescribed, according to eGFR alone, 
can be harmful to the patient, since both a sub-dose 
and overdose of medications can be harmful (Brown, 
Masselink, Lalla, 2013). 
Several broad-spectrum antibiotics, commonly 
used in ICU, are potentially nephrotoxic while are 
mainly excreted by the kidneys. Vancomycin, for 
example, is widely used for the treatment of infections 
caused by resistant strains of gram-positive bacteria but 
presents high nephrotoxicity rates (Luque, Mesnard, 
2018; Park et al., 2018). Other agents as piperacillin/
tazobactam, meropenem, imipenem and cefepime, 
active against gram-negative bacteria, are associated 
with lower nephrotoxic rates but may cause central 
nervous toxicity in overdose or can to potentiate the 
toxicity of other antibiotics such as vancomycin. Hence, 
using those broad-spectrum antibiotics require close 
attention in renal function aiming to avoid its depletion 
as well as to prevent kidneys or other organ injury 
caused by overdoses of these drugs resulting from loss 
of glomerular filtration (Cook et al., 2018).
Given the risks inherent to dose adjustment of 
certain drugs, it is necessary to consider which decision 
would carry reduced risk to the patient when there is 
a difference in the indication of dose adjustment. For 
example, in addition to higher costs, a higher than 
necessary dose carries a risk of adverse reactions, 
such as convulsion and myoclonus. Conversely, if the 
dose is lower than necessary, therapeutic failure may 
occur, thereby leading to an increased length of stay, a 
worsening of clinical status, and even death (Hudson, 
Mason, Huch, 2011; Nyman et al., 2011). Moreover, 
eGFR is also used to guide nutritional support and the 
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need for renal replacement therapy (Brown, Masselink, 
Lalla, 2013).
In 1998, the Food and Drug Administration (FDA) 
published guidelines for the pharmaceutical industry, 
which suggests the use of the CG equation to estimate 
renal function since it was the most commonly used 
equation for this purpose (FDA, 1998). In 2010, the 
FDA published new guidelines recommending the 
use of both the creatinine clearance level and GFR 
for drug dose adjustment, which makes it possible to 
use the MDRD-4 equation (FDA, 2010). However, for 
previously approved drugs, it is unlikely that any changes 
will be made, since tests have already been performed 
and these drugs are already on the market. Thus, for 
some drugs that have dose adjustment instructions 
based on the CG equation, the use of MDRD-4 may 
have important implications since this equation usually 
suggests higher doses than does CG, which results in 
a greater uncertainty in their implementation (Golik, 
Lawrence, 2008; Hermsen et al., 2009). 
The difficulty in estimating GFR in ICU patients is 
associated with several factors, such as sudden changes 
in renal volume and haemodynamic activity, which are 
common in this population. In individuals with frequent 
changes in serum creatinine concentration or with acute 
kidney injury, the use of equations should be performed 
with caution since none are considered safe in these 
cases and have not been completely validated for this 
purpose (Cockcroft, Gault, 1976; Levey et al., 2006; 
Sunder et al., 2014). Clinicians often suggest assessing 
urine for various markers over a period of 24 hours to 
estimate GFR. However, this method is not precise and 
requires additional resources and time to obtain results 
(El-Minshawy, Saber, Osman, 2010).
Choosing one over another between CG and MDRD 
may lead to the prescription of a medication overdose or to 
the treatment switch, based on the eGFR result. Various 
formulae were created after CG and considered better 
than it. However, there is no consensus on which one is 
better to estimate the GFR. Thus, the choice must take 
into consideration patients’ individual characteristics 
and the drug therapy aim, regarding risks and benefits 
(Cartet-Farnier et al., 2017; Delanaye et al., 2017).
We did not include in the comparison other 
equations to estimate GFR as the CKD-EPI Creatinine 
Equation. However, our results cover the majority of 
GFR estimations conducted in our settings, especially 
for doses adjustments, since CG and MDRD are most 
frequently applied. Moreover, we did not compare the 
eGFR by CG and MDRD with the creatinine clearance 
rate measured by gold-standards markers as iohexol or 
inulin because there are not often used in a routine basis.
This study demonstrated a significant difference 
in eGFR values when calculated using either CG or 
MDRD-4 as well as in the indication of dose adjustment 
of broad-spectrum antimicrobials administered to 
patients admitted in an ICU. In the analysis, weight and 
age have influenced for higher divergence between the 
eGFR obtained by the two equations.
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